<HashMap><database>panorama</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>0</viewCount><searchCount>0</searchCount></scores><additional><omics_type>Proteomics</omics_type><submitter>Atakan Arda Nalbant</submitter><species>Homo Sapiens</species><full_dataset_link>https://panoramaweb.org/COVID-PRM.url</full_dataset_link><submitter_email>atakan.nalbant@newcastle.ac.uk</submitter_email><submitter_affiliation>Newcastle University</submitter_affiliation><sample_protocol></sample_protocol><repository>PanoramaPublic</repository><data_protocol></data_protocol><pubmed_abstract>The on-going SARS-CoV-2 (COVID-19) pandemic has called for an urgent need for rapid and high-throughput methods for mass testing and early detection, prevention as well as surveillance of the disease. We investigated whether targeted parallel reaction monitoring (PRM) quantification using high resolution Orbitrap instruments can provide the sensitivity and speed required for a high-throughput method that could be used for clinical diagnosis. We developed a high-throughput and sensitive PRM-MS assay that enables absolute quantification of SARS-CoV-2 nucleocapsid peptides with short turn-around times by using isotopically labelled synthetic SARS-CoV-2 concatenated peptides. We established a fast and high-throughput S-trap-based sample preparation method and utilized it for testing 25 positive and 25 negative heat-inactivated clinical nasopharyngeal swab samples for SARS-CoV-2 detection. The method was able to differentiate between negative and some of the positive patients with high viral load. Moreover, based on the absolute quantification calculations, our data show that patients with Ct values as low as 17.8 correspond to NCAP protein amounts of around 7.5 pmol in swab samples. The present high-throughput method could potentially be utilized in specialized clinics as an alternative tool for detection of SARS-CoV-2 but will require enrichment of viral proteins in order to compete with RT-qPCR.</pubmed_abstract><pubmed_title>A fast and sensitive absolute quantification assay for the detection of SARS-CoV-2 peptides using parallel reaction monitoring mass spectrometry.</pubmed_title><pubmed_authors>Gajbhiye Akshada A, Nalbant Atakan A, Heunis Tiaan T, Sidgwick Frances F, Porter Andrew A, Taha Yusri Y, Trost Matthias M</pubmed_authors><description_synonyms>FBgn0003149, artificial sequence, Meth, determination, Burden, kinetic polymerase chain reaction, Virus Infection, 2019 novel coronavirus, protein, Virus Disease, 2019 nCoV Disease, prevention, RP11-508D10.1, Polypeptides, Tnfsf5, Techniques, Para, peptido, diseases, sampling sponge, Method, 2019-nCoV Disease, Novel Coronavirus, Virus, diseases and disorders, CG5939, protein aggregate, Fs(3)Hor, prevention and control, COVID 19 Pandemic, WMS, T-BAM, DmelCG2684, human disease, type 5 acid phosphatase, me75, Virus Titer, tartrate-resistant acid ATPase, peptides, Coronavirus Disease 2019, Coronavirus Disease-19, procedures, NTef2, beta-CoVs, D17Mit170, Fast, T1, Viral Gene Products, preventive measures, allergic reaction, reaction, TRAP3, T-cell antigen Gp39, Tudor repeat associator with PCTAIRE-2, Methodological Studies, Ice, scientific observation, Homo sapiens disease, TNFSF5, T5ap, GPHYSD2, MGC - 45012, COVID 19 Virus Disease, FAST, viral burden, SGS, 2019-nCoV Infections, CD40L, SARS-CoV-2 Viruses, preventive therapy, β-CoV, Viral, COVID-19 Viruses, DmelCG5939, Tnfrsf5, Cd40l, SARS-CoV-2, FASTK, Coronavirus 2, 2019 Novel Coronavirus Disease, 2019 nCoV Infection, Procedure, COVID 19 Virus Infection, Tl3, qPCR, Tl2, Fs(3)Sz11, ACMICD, hCD40L, shortened, COVID19 Viruses, prm, SARS-CoV-2 Virus, pmol, Diseases, IMD3, Coronavirus, l(3)S010605, TNF-related activation protein, COVID-19 Virus Infections, Ly-62, Crystal, quantitative real time polymerase chain reaction., specimen sponge, Pandemic, 0106/05, Coronavirus Disease 2019 Virus, PM/mPM, NKTL, viral titer, AW743063, Methodological, MASS, AI326936, Methodological Study, early, Speed, disease, SYNTHETIC CONSTRUCT sequences, Specificity and Sensitivity, Patient, Horka, TrATPase, Viral Burden, IGM, CG2684, 2019, Fs(3)Horka, artificial, 2019 Novel Coronavirus Infection, CD40LG, Viral Protein, 2019-nCoV Diseases, Polypeptide, short, COVID19, other disease, Procedures, TRAP, p50, Ly62, TAPK, COVID-19, nucleocapsid, STK10, FBN, Gene, COVID-19 Virus Diseases, SARS CoV 2 Virus, protein-containing complex, Chalk, TR-AP, COVID19 Virus, surface wipe, Load, method, SARS, ECTOL1, mPM, sensitive, method used in an experiment, GP39, SARS CoV 2 Infection, Tina, Studies, Gene Products, Severe Acute Respiratory Syndrome Coronavirus 2 Infection, disease or disorder, DmF2, Low, β-coronavirus, synthetic genetic interaction (sensu inequality), CD40-L, 2019-nCoV, Technique, sensitivity, 2019 Novel Coronaviruses, gp39, lod, CD154, absorbant pad, SARS Coronavirus 2, β-CoVs, Glass, Viruses, CATC4, GKLP, Wuhan Seafood Market Pneumonia Virus, COVID-19 Virus Infection, stubby, synthetic genetic interaction defined by inequality, severe acute respiratory syndrome coronavirus 2, viral titre, SARS-CoV-2 Infection, OCTD, non-neoplastic, Study, COVID-19 Virus, PCTAIRE2-binding protein, MGC:45012, TEIF, ATP:Fas-activated serine/threonine protein phosphotransferase activity, Trap, Clients, sample pad, disorder, Sensitivity, HIGM1, peptidos, SARS Coronavirus 2 Infection, Wuhan Coronavirus, C78062, measuring, P105, NTKL, Disease, Coronavirus Disease 19, 2019 Novel Coronavirus, cou, beta-CoV, protein complex, PCTAIRE2BP, Proteins, disorders, artificial gene, Bp50, medical condition, SARS-CoV-2 Infections, synthetic DNA, ACP5, SPENCDI, polysponge, Client, Peptide, COVID-19 Virus Disease, 2019-nCoV Infection, Viral Gene Proteins, Severe Acute Respiratory Syndrome Coronavirus 2, Lr, Nucleocapsids, native protein, chemical analysis, Protein, Infection, core, synthetic, condition, MFS1, swab, techniques, WMS2, Titer, 2019 Novel, betacoronavirus, Disease 2019, Q-PCR, prophylaxis, Specificity, Wuhan, COVID-19 Pandemics, COVID-19 Pandemic, Lds, synthetic constructs, SARS-coronavirus 2, plan specification, Protein Gene Products, Gene Proteins, l(3)10631, control, SSKS, Bra, Peptid, COVID 19 Virus, assay, TRACP, COVID 19, pm, PM, methodology</description_synonyms><pubmed_title_synonyms>measuring, COVID19, SARS-CoV-2 Viruses, 2019 Novel Coronavirus, β-CoV, determination, beta-CoV, COVID-19 Viruses, COVID-19, STK10, SARS-CoV-2, 2019 novel coronavirus, FASTK, Coronavirus 2, Spectrum Analyses, SARS CoV 2 Virus, Spectrum Analysis, Peptide, COVID19 Virus, Spectroscopy, Polypeptides, COVID19 Viruses, Severe Acute Respiratory Syndrome Coronavirus 2, MS, peptido, SARS, sensitive, SARS-CoV-2 Virus, chemical analysis, Novel Coronavirus, Virus, Mass, Coronavirus, β-coronavirus, Analysis, sensitivity, 2019-nCoV, Mass Spectrum Analyses, Mass Spectroscopy, 2019 Novel Coronaviruses, Mass Spectrum Analysis, Mass Spectrum, SARS Coronavirus 2, β-CoVs, 2019 Novel, betacoronavirus, Viruses, peptides, Analyses, Coronavirus Disease 2019 Virus, Wuhan Seafood Market Pneumonia Virus, Spectrometry, severe acute respiratory syndrome coronavirus 2, Wuhan, beta-CoVs, Fast, SARS-coronavirus 2, allergic reaction, COVID-19 Virus, reaction, ATP:Fas-activated serine/threonine protein phosphotransferase activity, scientific observation, Mass., 2019, Peptid, peptidos, COVID 19 Virus, assay, Polypeptide, FAST, Wuhan Coronavirus</pubmed_title_synonyms><name_synonyms>FBgn0003149, measuring, COVID19, SARS-CoV-2 Viruses, 2019 Novel Coronavirus, β-CoV, beta-CoV, determination, COVID-19 Viruses, DmelCG5939, COVID-19, SARS-CoV-2, 2019 novel coronavirus, Coronavirus 2, SARS CoV 2 Virus, COVID19 Virus, COVID19 Viruses, Para, Severe Acute Respiratory Syndrome Coronavirus 2, Client., SARS, prm, SARS-CoV-2 Virus, mPM, chemical analysis, Novel Coronavirus, Virus, Coronavirus, l(3)S010605, β-coronavirus, CG5939, 2019-nCoV, 2019 Novel Coronaviruses, SARS Coronavirus 2, β-CoVs, 2019 Novel, betacoronavirus, Viruses, 0106/05, Coronavirus Disease 2019 Virus, PM/mPM, Wuhan Seafood Market Pneumonia Virus, severe acute respiratory syndrome coronavirus 2, patient, Wuhan, beta-CoVs, SARS-coronavirus 2, COVID-19 Virus, l(3)10631, Patient, scientific observation, Clients, 2019, COVID 19 Virus, assay, Wuhan Coronavirus, pm, PM</name_synonyms><pubmed_abstract_synonyms>FBgn0003149, artificial sequence, Meth, determination, Burden, kinetic polymerase chain reaction, Virus Infection, 2019 novel coronavirus, protein, Virus Disease, 2019 nCoV Disease, prevention, RP11-508D10.1, Polypeptides, Tnfsf5, Techniques, Para, peptido, diseases, sampling sponge, Method, 2019-nCoV Disease, Novel Coronavirus, Virus, diseases and disorders, CG5939, protein aggregate, Fs(3)Hor, prevention and control, COVID 19 Pandemic, WMS, T-BAM, DmelCG2684, human disease, type 5 acid phosphatase, me75, Virus Titer, tartrate-resistant acid ATPase, peptides, Coronavirus Disease 2019, Coronavirus Disease-19, procedures, NTef2, beta-CoVs, D17Mit170, Fast, T1, Viral Gene Products, preventive measures, allergic reaction, reaction, TRAP3, T-cell antigen Gp39, Tudor repeat associator with PCTAIRE-2, Methodological Studies, Ice, scientific observation, Homo sapiens disease, TNFSF5, T5ap, GPHYSD2, MGC - 45012, COVID 19 Virus Disease, FAST, viral burden, SGS, 2019-nCoV Infections, CD40L, SARS-CoV-2 Viruses, preventive therapy, β-CoV, Viral, COVID-19 Viruses, DmelCG5939, Tnfrsf5, Cd40l, SARS-CoV-2, FASTK, Coronavirus 2, 2019 Novel Coronavirus Disease, 2019 nCoV Infection, Procedure, COVID 19 Virus Infection, Tl3, qPCR, Tl2, Fs(3)Sz11, ACMICD, hCD40L, shortened, COVID19 Viruses, prm, SARS-CoV-2 Virus, pmol, Diseases, IMD3, Coronavirus, l(3)S010605, TNF-related activation protein, COVID-19 Virus Infections, Ly-62, Crystal, quantitative real time polymerase chain reaction., specimen sponge, Pandemic, 0106/05, Coronavirus Disease 2019 Virus, PM/mPM, NKTL, viral titer, AW743063, Methodological, MASS, AI326936, Methodological Study, early, Speed, disease, SYNTHETIC CONSTRUCT sequences, Specificity and Sensitivity, Patient, Horka, TrATPase, Viral Burden, IGM, CG2684, 2019, Fs(3)Horka, artificial, 2019 Novel Coronavirus Infection, CD40LG, Viral Protein, 2019-nCoV Diseases, Polypeptide, short, COVID19, other disease, Procedures, TRAP, p50, Ly62, TAPK, COVID-19, nucleocapsid, STK10, FBN, Gene, COVID-19 Virus Diseases, SARS CoV 2 Virus, protein-containing complex, Chalk, TR-AP, COVID19 Virus, surface wipe, Load, method, SARS, ECTOL1, mPM, sensitive, method used in an experiment, GP39, SARS CoV 2 Infection, Tina, Studies, Gene Products, Severe Acute Respiratory Syndrome Coronavirus 2 Infection, disease or disorder, DmF2, Low, β-coronavirus, synthetic genetic interaction (sensu inequality), CD40-L, 2019-nCoV, Technique, sensitivity, 2019 Novel Coronaviruses, gp39, lod, CD154, absorbant pad, SARS Coronavirus 2, β-CoVs, Glass, Viruses, CATC4, GKLP, Wuhan Seafood Market Pneumonia Virus, COVID-19 Virus Infection, stubby, synthetic genetic interaction defined by inequality, severe acute respiratory syndrome coronavirus 2, viral titre, SARS-CoV-2 Infection, OCTD, non-neoplastic, Study, COVID-19 Virus, PCTAIRE2-binding protein, MGC:45012, TEIF, ATP:Fas-activated serine/threonine protein phosphotransferase activity, Trap, Clients, sample pad, disorder, Sensitivity, HIGM1, peptidos, SARS Coronavirus 2 Infection, Wuhan Coronavirus, C78062, measuring, P105, NTKL, Disease, Coronavirus Disease 19, 2019 Novel Coronavirus, cou, beta-CoV, protein complex, PCTAIRE2BP, Proteins, disorders, artificial gene, Bp50, medical condition, SARS-CoV-2 Infections, synthetic DNA, ACP5, SPENCDI, polysponge, Client, Peptide, COVID-19 Virus Disease, 2019-nCoV Infection, Viral Gene Proteins, Severe Acute Respiratory Syndrome Coronavirus 2, Lr, Nucleocapsids, native protein, chemical analysis, Protein, Infection, core, synthetic, condition, MFS1, swab, techniques, WMS2, Titer, 2019 Novel, betacoronavirus, Disease 2019, Q-PCR, prophylaxis, Specificity, Wuhan, COVID-19 Pandemics, COVID-19 Pandemic, Lds, synthetic constructs, SARS-coronavirus 2, plan specification, Protein Gene Products, Gene Proteins, l(3)10631, control, SSKS, Bra, Peptid, COVID 19 Virus, assay, TRACP, COVID 19, pm, PM, methodology</pubmed_abstract_synonyms><citation_count>0</citation_count></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 PRM-MS Assay with Clinical Patient Samples</name><description>The on-going SARS-CoV-2 (COVID-19) pandemic has called for an urgent need for rapid and high-throughput methods for mass testing for early detection, prevention and surveillance of the disease. We investigated whether targeted parallel reaction monitoring (PRM) quantification using high resolution Orbitrap instruments can provide the sensitivity and speed required for a high-throughput method that could be used for clinical diagnosis. We developed a high-throughput and sensitive PRM-MS assay that enables absolute quantification of SARS-CoV-2 nucleocapsid peptides with short turn-around times by using isotopically labelled synthetic SARS-CoV-2 concatenated peptides. We established a fast and high-throughput S-trap-based sample preparation method, which was then utilized for testing 25 positive and 25 negative heat-inactivated nasopharyngeal swab samples for SARS-CoV-2 detection. The method was able to differentiate between negative and some of the positive patients with high viral load .Moreover, based on the absolute quantification calculations, our data show that patients with Ct values as low as 17.5 correspond to NCAP protein amounts of around 7.5 pmol in swab samples. The present high-throughput method could potentially be utilized in specialized clinics as an alternative tool for detection of SARS-CoV-2 but will require enrichment of viral proteins in order to compete with RT-qPCR.</description><dates><publication>Fri Jun 24 00:00:00 GMT+01:00 2022</publication></dates><accession>PXD033790</accession><cross_references><TAXONOMY>9606</TAXONOMY><pubmed>35732269</pubmed></cross_references></HashMap>